background
compar
yield
respiratori
viru
detect
nasopharyng
aspir
npa
versu
bronchoalveolar
lavag
bal
uncertain
furthermor
signific
viru
detect
relationship
lower
airway
neutrophil
inflamm
poorli
studi
object
evalu
sensit
specif
predict
valu
npa
detect
respiratori
virus
bal
determin
relationship
virus
lower
airway
neutrophilia
children
nonacut
respiratori
ill
studi
design
pair
npa
bal
sampl
obtain
children
age
year
undergo
flexibl
bronchoscopi
investig
chronic
respiratori
symptom
viral
studi
perform
use
polymeras
chain
reaction
pcr
cellular
studi
perform
bal
diagnost
paramet
npa
compar
bal
associ
virus
lower
airway
neutrophil
evalu
result
npa
higher
yield
bal
detect
respiratori
viru
versu
respect
npa
high
sensit
low
specif
detect
hrv
bal
poor
kappa
agreement
valu
ci
p
npa
fair
sensit
good
specif
detect
hadv
bal
kappa
agreement
ci
p
hadv
posit
npa
compar
neg
independ
associ
heighten
airway
neutrophilia
mean
differ
ci
p
conclus
npa
higher
yield
respiratori
viru
detect
bal
howev
diagnost
accuraci
depend
viral
speci
adenoviru
posit
associ
significantli
heighten
lower
airway
neutrophilia
children
chronic
respiratori
symptom
crown
accur
identif
respiratori
pathogen
import
clinic
medicin
research
bacteriolog
upper
airway
sampl
misrepres
lower
airway
microbiota
contrast
littl
compar
data
virolog
nasopharyng
aspir
npa
nasal
wash
regard
specimen
choic
detect
upper
respiratori
tract
virus
polymeras
chain
reaction
pcr
upper
airway
sampl
rel
simpl
perform
bedsid
minim
invas
contrast
lower
airway
sampl
young
children
invas
requir
bronchoalveolar
lavag
bal
tradit
bal
consid
goldstandard
microbiolog
diagnosi
viral
bacteri
lower
respiratori
tract
infect
children
howev
bal
requir
specialist
input
often
perform
anesthesia
reserv
patient
complex
sever
diseas
eg
set
intens
care
immunecompromis
children
chronic
recurr
respiratori
tract
symptom
dispar
eas
collect
npa
versu
bal
rais
two
import
question
firstli
compar
yield
npa
compar
bal
respiratori
viru
detect
children
secondli
signific
posit
npa
respect
lower
airway
inflamm
given
lack
studi
address
import
question
evalu
pair
npa
bal
specimen
children
compar
yield
diagnost
paramet
respiratori
viru
detect
npa
versu
bal
use
molecular
method
evalu
whether
viru
posit
npa
correl
lower
airway
neutrophil
inflamm
infer
activ
viral
pulmonari
diseas
queensland
children
health
servic
ethic
committe
approv
studi
written
inform
consent
obtain
parent
guardian
children
undergo
flexibl
bronchoscopi
clinic
indic
arrang
treat
physician
elig
sampl
evalu
articl
obtain
children
recruit
larger
cohort
studi
chronic
cough
children
caregiv
complet
standard
clinic
questionnair
day
bronchoscopi
includ
current
respiratori
symptom
relev
demograph
children
symptom
signific
acut
lower
respiratori
tract
infect
eg
high
fever
tachypneashort
breath
wheez
rattli
chest
deem
anesthetist
unfit
anesthesia
exclud
studi
contemporan
npa
bal
sampl
perform
gener
anesthesia
npa
collect
first
use
dispos
cathet
connect
mucou
trap
dri
nasopharyng
suction
via
nare
perform
follow
suction
ml
steril
normal
salin
directli
suction
cathet
rins
remain
content
bronchoscop
bal
perform
use
standard
method
per
european
respiratori
societi
guidelin
steril
normal
salin
three
aliquot
mlkg
maximum
ml
instil
affect
area
right
middl
lobe
patient
gener
diseas
minim
upper
airway
contamin
suction
bronchoscop
avoid
tip
enter
distal
airway
first
aliquot
use
microbiolog
test
second
third
pool
cellular
studi
viral
studi
undertaken
use
realtim
pcr
techniqu
describ
previous
detect
respiratori
viru
type
subtyp
includ
human
rhinovirus
hrv
human
adenovirus
hadv
respiratori
syncyti
viru
rsv
human
influenza
viru
ifav
human
influenza
b
viru
ifbv
human
parainfluenza
viru
human
metapneumoviru
hmpv
human
bocaviru
hbov
human
coronavirus
hcov
wu
polyomaviru
wupyv
ki
polyomaviru
kipyv
bal
specimen
refriger
immedi
process
within
h
npa
specimen
store
c
prior
process
defin
posit
bacteri
cultur
growth
colonyform
unit
cfu
ml
follow
pathogen
bal
streptococcu
pneumonia
moraxella
catarrhali
haemophilu
influenza
pseudomona
aeruginosa
staphylococcu
aureu
enterobacteriacea
total
cell
count
differenti
profil
minimum
cell
count
perform
bal
describ
previous
statist
analys
carri
use
ibm
spss
san
francisco
usa
median
interquartil
rang
report
data
nonnorm
distribut
kappa
analys
use
assess
level
agreement
sampl
techniqu
comparison
categor
variabl
perform
use
pearson
test
fisher
exact
test
categori
expect
valu
mannwhitney
u
test
use
two
group
comparison
kruskalw
test
group
comparison
continu
variabl
multipl
linear
regress
employ
adjust
viru
codetect
bacteri
infect
twotail
pvalu
consid
statist
signific
sensit
specif
posit
neg
predict
valu
likelihood
ratio
manual
calcul
februari
may
pair
npa
bal
sampl
obtain
children
median
age
month
iqr
male
n
onethird
children
n
expos
household
cigarett
smoke
chronic
cough
week
report
particip
time
bronchoscopi
major
diagnos
within
cohort
includ
protract
bacteri
bronchiti
n
bronchiectasi
n
remain
particip
either
specif
diagnosi
n
congenit
airway
abnorm
n
common
virus
detect
npa
hrv
n
hadv
n
regard
season
hadv
posit
bal
like
occur
spring
summer
winter
autumn
p
use
chisquar
analysi
hrv
detect
follow
bimod
distribut
peak
detect
occur
spring
autumn
pair
npa
bal
sampl
children
one
viru
detect
npa
one
viru
bal
consid
detect
viru
npabal
pair
concord
pcrposit
pair
concord
pcrneg
pair
discord
pcr
result
discord
pair
n
pcr
posit
npa
neg
bal
detect
rate
vari
among
differ
virus
tabl
mark
differ
npa
bal
hrv
use
posit
pcr
bal
arbitrari
gold
standard
calcul
sensit
specif
posit
neg
predict
valu
likelihood
ratio
tabl
hrv
hadv
common
virus
detect
npa
bal
level
agreement
npa
bal
vari
among
differ
virus
agreement
npa
bal
hrv
poor
kappa
ci
p
good
hadv
ci
p
median
lower
airway
neutrophil
significantli
higher
children
npaposit
viru
compar
respect
p
median
lower
airway
tcc
higher
bal
virusposit
l
iqr
versu
virusneg
l
group
p
differ
lymphocyt
count
observ
consid
total
virus
individu
virus
lymphocyt
significantli
lower
hadv
bal
posit
compar
hadv
bal
neg
particip
p
children
hadv
posit
bal
higher
neutrophil
hadv
neg
bal
p
comparison
neutrophil
similar
across
hrv
posit
neg
group
bal
p
multivari
analysi
hrv
either
npa
bal
show
associ
lower
airway
neutrophil
contrast
hadv
npa
andor
bal
significantli
associ
increas
neutrophil
bal
tabl
bacteri
infect
detect
half
npa
viru
posit
particip
much
lower
rate
viru
neg
particip
p
rate
bacteri
infect
bal
viru
posit
children
also
greater
bal
viru
neg
children
howev
differ
signific
p
predomin
bacteri
organ
h
influenza
catarrhali
pneumonia
presenc
bacteri
infect
seen
bal
strongest
independ
influenc
lower
airway
neutrophil
count
beta
npa
bal
respect
shown
tabl
studi
systemat
compar
upper
airway
npa
lower
airway
bal
sampl
regard
diagnost
yield
respiratori
virus
children
nonacut
respiratori
ill
found
concord
npa
bal
larg
depend
viru
investig
npa
good
concord
bal
detect
hadv
poor
concord
hrv
comparison
bal
sensit
specif
ppv
npv
frequent
detect
virus
npa
differ
accord
viru
investig
specif
high
virus
except
hrv
revers
observ
regard
sensit
lastli
presenc
hadv
npa
andor
bal
associ
significantli
heighten
neutrophil
lower
airway
knowledg
three
major
studi
compar
upper
lower
airway
specimen
respiratori
viru
detect
limit
unpair
specimen
focus
specif
diseas
virus
first
compar
npa
bal
lung
transplant
recipi
use
unpair
noncontemporan
npa
bal
specimen
obtain
particip
npa
bal
respect
higher
yield
hmpv
seen
npa
compar
bal
compar
rate
ifav
hpiv
rsv
hcov
hrv
diagnost
accuraci
npa
bal
assess
studi
second
studi
use
pair
specimen
obtain
particip
occas
compar
induc
sputum
npa
detect
respiratori
virus
children
cystic
fibrosi
hrv
common
viru
identifi
present
frequenc
npa
sputum
concord
rate
higher
present
studi
hrv
virus
higher
sensit
specif
respect
third
studi
compar
pair
nasal
washtrach
suction
specimen
bal
term
rsv
detect
particip
found
bal
superior
detect
rsv
use
antigen
detect
cultur
method
insensit
method
compar
pcr
studi
directli
compar
npa
bal
focus
atyp
pneumonia
first
studi
evalu
pneumocysti
jiroveci
pneumonia
second
compar
detect
method
mycoplasma
pneumonia
studi
found
high
concord
npa
bal
howev
contrast
find
studi
bal
higher
yield
posit
detect
npa
interestingli
studi
mycoplasma
pneumonia
bal
posit
associ
increas
lower
airway
neutrophil
howev
npa
posit
differ
find
may
reflect
differ
mode
transmiss
mechan
diseas
progress
viral
bacteri
infect
respiratori
tract
studi
show
npabal
discord
mark
hrv
children
npaposit
balneg
contrast
hadv
like
also
found
lower
airway
npapositivebalneg
children
previou
studi
found
hrv
greater
propens
infect
nasopharynx
proxim
lower
airway
distal
airway
alveoli
may
relat
hrv
abil
replic
optim
cooler
temperatur
upper
airway
although
find
inconsist
across
hrv
type
vivo
studi
demonstr
hrv
induc
minim
epitheli
cytotox
small
subset
nasal
bronchial
mucos
cell
becom
infect
factor
may
explain
hrv
uncommon
caus
pneumonia
except
immunecompromis
host
whilst
hrv
hadv
caus
uncompl
upper
respiratori
tract
infect
diseas
manifest
differ
sever
end
spectrum
hrv
shown
play
import
role
asthma
exacerb
hadv
implic
pathogenesi
oblit
bronchiol
bronchiectasi
thu
differ
hadv
hrv
mechan
propag
respiratori
diseas
pathogenesi
like
explain
observ
crosssect
find
elev
rate
hrv
children
essenti
free
acut
rvi
symptom
higher
prior
studi
show
asymptomat
hrv
nasopharyng
detect
rang
hrv
frequent
identifi
patient
viral
bacteri
coinfect
fact
may
relev
cohort
children
high
rate
bacteri
infect
chronic
cough
understand
implic
find
relat
lower
airway
neutrophil
inflamm
viru
detect
distinct
posit
viru
detect
activ
viral
diseas
merit
discuss
pcrposit
npa
child
without
overt
symptom
acut
rvi
often
believ
repres
viral
genom
shed
resolv
infect
preced
new
symptomat
episod
howev
certain
hadv
type
caus
prolong
host
shed
intermitt
viral
excret
month
year
contrast
hrv
usual
persist
garnett
et
al
postul
smolder
hadv
site
lung
inflamm
may
contribut
pathogenesi
lung
diseas
chronic
obstruct
pulmonari
diseas
copd
adult
find
low
bal
lymphocyt
togeth
neutrophilia
children
hadv
dna
posit
bal
support
notion
activ
lower
airway
hadv
replic
like
occur
oppos
latent
hadv
infect
lymphocyt
whether
persist
hadv
viral
dna
within
respiratori
tract
children
benign
contribut
develop
chronic
lung
diseas
unknown
major
strength
studi
prospect
design
use
highli
sensit
pcr
techniqu
detect
wide
rang
respiratori
virus
contemporan
detect
lower
airway
bacteria
inclus
bal
cellular
find
howev
number
limit
firstli
studi
involv
children
chronic
respiratori
symptom
predominantli
cough
henc
find
may
readili
extrapol
healthi
children
acut
lower
respiratori
tract
ill
particularli
pertin
influenza
rsv
children
virus
detect
secondli
use
neutrophil
lower
airway
inflamm
surrog
marker
activ
pulmonari
diseas
use
author
howev
test
addit
indirect
marker
viral
infect
tolllik
receptor
interferon
gamma
induc
protein
virusspecif
antibodi
thirdli
obtain
bal
sampl
singl
timepoint
preclud
abil
make
infer
regard
causal
lastli
although
fastidi
bal
techniqu
contamin
bronchoscop
rout
upper
airway
possibl
signific
number
bal
positivenpa
neg
case
howev
negat
argument
contamin
could
account
lower
airway
detect
conclus
shown
upper
airway
sampl
practic
frequent
use
method
assess
viru
presenc
necessarili
reflect
viru
lower
airway
children
nonacut
respiratori
ill
howev
certain
virus
eg
hadv
detect
npa
may
provid
clue
exist
lower
airway
neutrophil
inflamm
research
need
studi
address
acut
viral
respiratori
tract
ill
children
requir
ascertain
applic
find
acut
set
dr
wurzel
coconceptu
studi
respons
data
analysi
manuscript
prepar
involv
data
collect
dr
marchant
coconceptu
studi
assist
data
analysi
manuscript
prepar
dr
clark
provid
intellectu
input
studi
critic
review
manuscript
dr
mackay
ms
wang
respons
viral
process
specimen
critic
review
manuscript
prof
sloot
respons
viral
process
specimen
critic
review
manuscript
prof
upham
dr
yerkovich
assist
prepar
critic
review
manuscript
assoc
prof
master
assist
data
collect
critic
review
manuscript
dr
baker
assist
statist
aspect
studi
ms
andersonjam
assist
data
collect
studi
coordin
prof
chang
conceptu
studi
involv
aspect
studi
author
read
approv
final
manuscript
submit
work
support
financi
market
foundat
children
project
grant
royal
children
hospit
foundat
thorac
societi
australia
new
zealandallen
hanburi
queensland
children
medic
research
institut
dw
nation
health
medic
research
council
ac
ju
dw
im
receiv
payment
consult
servic
firebrick
pharma
ju
serv
advisori
board
novarti
previous
receiv
payment
lectur
serv
speaker
bureau
astrazeneca
gsk
novarti
boehring
author
report
potenti
conflict
ethic
approv
given
queensland
children
health
servic
rch
human
research
ethic
committe
hrec
refer
number
